Agilent Technologies Inc. (NYSE: A) has
announced that Accelicon Technologies' software solutions and technology for
device-level modeling and validation in the electronics industry are now part
of Agilent. The two companies had announced an acquisition agreement on Dec. 1,
2011. Financial details were not disclosed.
The acquisition, led by Agilent's EEsof
EDA organization, further enhances Agilent's leadership in semiconductor device
modeling. Accurate, verified device models are critical to reduce R&D
design cycles as higher frequencies, smaller technology nodes, new materials
and device layouts call for more accurate process design kits. As part of the
Software and Modular Solutions Division, Agilent EEsof continues to integrate
its industry-leading design simulation with real measurements to improve design
efficiency for engineers who develop communications systems. These improved
tools and processes solve the increasing complexities they face when designing
communications systems for aerospace/defense and commercial wireless
applications.
Accelicon was founded in 2002 by noted
industry veteran Dr. Xisheng Zhang, who has now joined Agilent along with
former Accelicon CEO Tim K. Smith. The majority of the former Accelicon
employees are located in Beijing; they are also now part of Agilent.
About Agilent EEsof EDA Software
Agilent EEsof EDA is the leading
supplier of electronic design automation software for microwave, RF,
high-frequency, high-speed digital, RF system, electronic system level,
circuit, 3-D electromagnetic, physical design and device-modeling applications.
More information is available at www.agilent.com/find/eesof.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is
the world's premier measurement company and a technology leader in chemical
analysis, life sciences, electronics and communications. The company's 18,700
employees serve customers in more than 100 countries. Agilent had net revenues
of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.